Skip to main content
. 2012 Sep 20;56(1):131–139. doi: 10.1093/cid/cis808

Figure 2.

Figure 2.

Estimated cumulative risk (with 95% confidence intervals) of (A) human immunodeficiency virus type 1 (HIV-1) infection or (B) HIV-1 infection or death by 28 weeks among infants HIV-1 uninfected at birth by study arm. Abbreviations: AZT, zidovudine; BAN, Breastfeeding, Antiretrovirals and Nutrition study; HIV-1, human immunodeficiency virus type 1; NVP, nevirapine; PEPI, Post-Exposure Prophylaxis of the Infant study; SWEN, Six-Week Extended Nevirapine study.